{"nct_id":"NCT00113802","title":"Study of Epratuzumab (hLL2) in Patients With Waldenstrom's Macroglobulinemia","status":"TERMINATED","status_verified_date":"2008-02","start_date":"2004-08","start_date_type":null,"primary_completion_date":"2006-12","primary_completion_date_type":"ACTUAL","completion_date":"2006-12","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["GILD"]}